Cortinovis D - Search Results

1

Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.

Bordoni R, Ciardiello F, von Pawel J, Cortinovis D, Karagiannis T, Ballinger M, Sandler A, Yu W, He P, Matheny C, Felizzi F, Rittmeyer A. Bordoni R, et al. Among authors: cortinovis d. Clin Lung Cancer. 2018 Sep;19(5):441-449.e4. doi: 10.1016/j.cllc.2018.05.011. Epub 2018 May 31. Clin Lung Cancer. 2018. PMID: 30017645 Free article. Clinical Trial.

2

Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer.

Bidoli P, Stani SC, Mariani L, De Candis D, Cortinovis D, Aglione S, Zilembo N, Toffolatti L, Formisano B, Bajetta E. Bidoli P, et al. Among authors: cortinovis d. Lung Cancer. 2004 Feb;43(2):203-8. doi: 10.1016/j.lungcan.2003.09.003. Lung Cancer. 2004. PMID: 14739041 Clinical Trial.

3

Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.

Gridelli C, Ferrara C, Guerriero C, Palazzo S, Grasso G, Pavese I, Satta F, Bajetta E, Cortinovis D, Barbieri F, Gebbia V, Grossi F, Novello S, Baldini E, Gasparini G, Latino W, Durante E, Giustini L, Negrini C. Gridelli C, et al. Among authors: cortinovis d. J Thorac Oncol. 2007 Jun;2(6):475-80. doi: 10.1097/01.JTO.0000275342.47584.f3. J Thorac Oncol. 2007. PMID: 17545841 Free article.

4

Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?

Cortinovis D, Bidoli P, Cullurà D, Lorusso V, Ardizzoia A, Amoroso V, Bandera M, Aitini E, Fusi A, Zilembo N, Radula D, Bajetta E. Cortinovis D, et al. J Thorac Oncol. 2008 Apr;3(4):405-11. doi: 10.1097/JTO.0b013e318168f780. J Thorac Oncol. 2008. PMID: 18379360 Free article. Clinical Trial.

5

Oxaliplatin doublets in non-small cell lung cancer: a literature review.

Cortinovis D, Bidoli P, Zilembo N, Fusi A, Bajetta E. Cortinovis D, et al. Lung Cancer. 2008 Jun;60(3):325-31. doi: 10.1016/j.lungcan.2008.03.005. Epub 2008 Apr 25. Lung Cancer. 2008. PMID: 18440088 Review.

6

Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer.

Bidoli P, Cortinovis DL, Colombo I, Crippa A, Cicchiello F, Villa F, Cazzaniga ME, Altomare G. Bidoli P, et al. J Thorac Oncol. 2010 Oct;5(10):1662-3. doi: 10.1097/JTO.0b013e3181ec1729. J Thorac Oncol. 2010. PMID: 20871265 Free article.

7

Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).

Banna GL, Di Maio M, Follador A, Collovà E, Menis J, Novello S, Bria E; ISA Co-Authors; Airoldi M, Amoroso D, Ardizzoia A, Aurilio G, Bajetta E, Ballardini P, Barbieri F, Barletta E, Balzelloni ML, Basso U, Bernardini I, Boni C, Bordin V, Bretti S, Bronte G, Brunetti C, Buti S, Capanna L, Colombo A, Condemi G, Cortinovis D, Dambrosio M, Di Fonzo C, Di Lucca G, Dima G, Falzetta A, Favaretto A, Ferraù F, Garetto L, Gebbia V, Genestreti G, Gentile AL, Giovanardi F, Labianca R, Lorusso V, Mantovani G, Martelli O, Massari F, Mazzoli M, Michetti G, Mordenti P, Mucciarini C, Munao S, Nacci A, Pogliani C, Procopio G, Riccardi F, Rizzato S, Rossi A, Rosti G, Russo P, Saladino T, Salesi N, Santangelo D, Sava T, Savarino A, Spinnato F, Tiseo M, Tomassi O, Tondulli L, Tonini G, Turano S, Valerio MR, Verderame F, Zanelli F, Zanon E. Banna GL, et al. Among authors: cortinovis d. Lung Cancer. 2011 Jul;73(1):78-88. doi: 10.1016/j.lungcan.2010.10.020. Epub 2010 Dec 8. Lung Cancer. 2011. PMID: 21144614

8

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence.

Gridelli C, De Marinis F, Di Maio M, Cortinovis D, Cappuzzo F, Mok T. Gridelli C, et al. Among authors: cortinovis d. Lung Cancer. 2011 Mar;71(3):249-57. doi: 10.1016/j.lungcan.2010.12.008. Epub 2011 Jan 8. Lung Cancer. 2011. PMID: 21216486 Review.

9

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues.

Gridelli C, De Marinis F, Di Maio M, Cortinovis D, Cappuzzo F, Mok T. Gridelli C, et al. Among authors: cortinovis d. Lung Cancer. 2011 Apr;72(1):3-8. doi: 10.1016/j.lungcan.2010.12.009. Epub 2011 Jan 8. Lung Cancer. 2011. PMID: 21216488 Review.

10

MicroRNAs in non-small cell lung cancer: current status and future therapeutic promises.

Cortinovis D, Monica V, Pietrantonio F, Ceresoli GL, La Spina CM, Wannesson L. Cortinovis D, et al. Curr Pharm Des. 2014;20(24):3982-90. doi: 10.2174/13816128113196660755. Curr Pharm Des. 2014. PMID: 24138721 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters